LaPlume Joseph W's Form 4 filing
Charles River Laboratories International, Inc. (CRL) · filed Aug 14, 2023
- Accession no.
- 0001127602-23-022480
- Filed
- Aug 14, 2023
- Trade date
- Aug 10, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $151.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| LaPlume Joseph WCIK 0001767215 | Officer (EVP, Corp Strategy & Develop) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | Common Stock | SSaleDisposed | −700 | $216.52 | −$151,564 | 24,983 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.